Dermisonics Stock Performance
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Dermisonics are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Dermisonics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dermisonics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders. ...more
Dermisonics | Build AI portfolio with Dermisonics Stock |
Dermisonics Relative Risk vs. Return Landscape
If you would invest 0.00 in Dermisonics on September 27, 2025 and sell it today you would earn a total of 0.00 from holding Dermisonics or generate 0.0% return on investment over 90 days. Dermisonics is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Dermisonics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Dermisonics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dermisonics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Dermisonics, and traders can use it to determine the average amount a Dermisonics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DMSI |
Based on monthly moving average Dermisonics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Dermisonics by adding Dermisonics to a well-diversified portfolio.
Dermisonics Fundamentals Growth
Dermisonics Stock prices reflect investors' perceptions of the future prospects and financial health of Dermisonics, and Dermisonics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Dermisonics Stock performance.
| Return On Equity | -3.92 | ||||
| Return On Asset | -0.12 | ||||
| Current Valuation | 63.91 K | ||||
| Shares Outstanding | 63.91 M | ||||
| Price To Earning | (0.02) X | ||||
| Cash And Equivalents | 22.77 K | ||||
| Total Debt | 2.56 M | ||||
| Book Value Per Share | (0.09) X | ||||
| Cash Flow From Operations | (1.3 M) | ||||
| Earnings Per Share | (0.44) X | ||||
| Total Asset | 20.08 M | ||||
| Retained Earnings | (16.49 M) | ||||
| Current Asset | 27 K | ||||
| Current Liabilities | 1.98 M | ||||
About Dermisonics Performance
By evaluating Dermisonics' fundamental ratios, stakeholders can gain valuable insights into Dermisonics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Dermisonics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Dermisonics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Dermisonics, Inc. manufactures ultrasonic transdermal drug-delivery technologies and equipment. Dermisonics, Inc. was founded in 2000 and is based in Irvine, California. Dermisonics is traded on OTC Exchange in the United States.Things to note about Dermisonics performance evaluation
Checking the ongoing alerts about Dermisonics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Dermisonics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Dermisonics generated a negative expected return over the last 90 days | |
| Dermisonics has some characteristics of a very speculative penny stock | |
| Dermisonics currently holds 2.56 M in liabilities. Dermisonics has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Dermisonics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Dermisonics currently holds about 22.77 K in cash with (1.3 M) of positive cash flow from operations. |
- Analyzing Dermisonics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Dermisonics' stock is overvalued or undervalued compared to its peers.
- Examining Dermisonics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Dermisonics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Dermisonics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Dermisonics' stock. These opinions can provide insight into Dermisonics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Dermisonics Stock analysis
When running Dermisonics' price analysis, check to measure Dermisonics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermisonics is operating at the current time. Most of Dermisonics' value examination focuses on studying past and present price action to predict the probability of Dermisonics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermisonics' price. Additionally, you may evaluate how the addition of Dermisonics to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |